DaVita Inc. (DVA)

Market Cap	13.69B
Revenue (ttm)	12.52B
Net Income (ttm)	859.62M
Shares Out	83.90M
EPS (ttm)	9.38
PE Ratio	17.40
Forward PE	15.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	484,499
Open	160.81
Previous Close	161.54
Day's Range	160.26 - 163.48
52-Week Range	75.47 - 168.50
Beta	0.87
Analysts	Hold
Price Target	155.60 (-4.63%)
Earnings Date	Oct 29, 2024

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 31, 1995
• Employees: 70,000
• Stock Exchange: NYSE
• Ticker Symbol: DVA
• Website: https://www.davita.com

Financial Performance

In 2023, DaVita's revenue was $12.14 billion, an increase of 4.57% compared to the previous year's $11.61 billion. Earnings were $691.54 million, an increase of 23.40%.

Analyst Forecast

According to 5 analysts, the average rating for DVA stock is "Hold." The 12-month stock price forecast is $155.6, which is a decrease of -4.63% from the latest price.

Price Target

$155.6

(-4.63% downside)

Analyst Consensus: Hold